| Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma F Peng, R Wang, Y Zhang, Z Zhao, W Zhou, Z Chang, H Liang, W Zhao, ... Molecular cancer 16, 1-12, 2017 | 123 | 2017 |
| Identification of differentially expressed miRNAs in individual breast cancer patient and application in personalized medicine F Peng, Y Zhang, R Wang, W Zhou, Z Zhao, H Liang, L Qi, W Zhao, ... Oncogenesis 5 (2), e194-e194, 2016 | 38 | 2016 |
| Individualized lncRNA differential expression profile reveals heterogeneity of breast cancer Z Zhao, YY Guo, Y Liu, L Sun, B Chen, C Wang, T Chen, Y Wang, Y Li, ... Oncogene 40 (27), 4604-4614, 2021 | 33 | 2021 |
| EMT-Regulome: a database for EMT-related regulatory interactions, motifs and network Z Zhao, W Zhou, Y Han, F Peng, R Wang, R Yu, C Wang, H Liang, Z Guo, ... Cell death & disease 8 (6), e2872-e2872, 2017 | 28 | 2017 |
| Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma K Liu, Y Geng, L Wang, H Xu, M Zou, Y Li, Z Zhao, T Chen, F Xu, L Sun, ... Molecular oncology 16 (16), 3034-3051, 2022 | 21 | 2022 |
| Identification of driver copy number alterations in diverse cancer types and application in drug repositioning W Zhou, Z Zhao, R Wang, Y Han, C Wang, F Yang, Y Han, H Liang, L Qi, ... Molecular oncology 11 (10), 1459-1474, 2017 | 21 | 2017 |
| Genetic interaction-based biomarkers identification for drug resistance and sensitivity in cancer cells Y Han, C Wang, Q Dong, T Chen, F Yang, Y Liu, B Chen, Z Zhao, L Qi, ... Molecular Therapy-Nucleic Acids 17, 688-700, 2019 | 20 | 2019 |
| A landscape of synthetic viable interactions in cancer Y Gu, R Wang, Y Han, W Zhou, Z Zhao, T Chen, Y Zhang, F Peng, ... Briefings in bioinformatics 19 (4), 644-655, 2018 | 17 | 2018 |
| Link synthetic lethality to drug sensitivity of cancer cells R Wang, Y Han, Z Zhao, F Yang, T Chen, W Zhou, X Wang, L Qi, W Zhao, ... Briefings in bioinformatics 20 (4), 1295-1307, 2019 | 15 | 2019 |
| Biased influences of low tumor purity on mutation detection in cancer J Cheng, J He, S Wang, Z Zhao, H Yan, Q Guan, J Li, Z Guo, L Ao Frontiers in molecular biosciences 7, 533196, 2020 | 14 | 2020 |
| A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level S Zhuang, T Chen, Y Li, Y Wang, L Ai, Y Geng, M Zou, K Liu, H Xu, ... Molecular Therapy-Nucleic Acids 26, 1014-1026, 2021 | 11 | 2021 |
| Upregulation of CXCL1 and LY9 contributes to BRCAness in ovarian cancer and mediates response to PARPi and immune checkpoint blockade T Chen, T Yu, S Zhuang, Y Geng, J Xue, J Wang, L Ai, B Chen, Z Zhao, ... British Journal of Cancer 127 (5), 916-926, 2022 | 8 | 2022 |
| Discovering a qualitative transcriptional signature of homologous recombination defectiveness for prostate cancer Y Li, Z Zhao, L Ai, Y Wang, K Liu, B Chen, T Chen, S Zhuang, H Xu, M Zou, ... Iscience 24 (10), 2021 | 8 | 2021 |
| Multilevel prioritization of gene regulators associated with consensus molecular subtypes of colorectal cancer K Song, H Cai, H Zheng, J Yang, L Jin, H Xiao, J Zhang, Z Zhao, X Li, ... Briefings in bioinformatics 22 (5), bbab077, 2021 | 8 | 2021 |
| Reference genome and annotation updates lead to contradictory prognostic predictions in gene expression signatures: a case study of resected stage I lung adenocarcinoma Z Zhang, S Zhang, X Li, Z Zhao, C Chen, J Zhang, M Li, Z Wei, W Jiang, ... Briefings in Bioinformatics 22 (3), bbaa081, 2021 | 8 | 2021 |
| RHPCG: a database of the Regulation of the Hippo Pathway in Cancer Genome C Wang, F Yang, T Chen, Q Dong, Z Zhao, Y Liu, B Chen, H Liang, ... Database 2019, baz135, 2019 | 7 | 2019 |
| Up-regulated SPP1 increases the risk from IPF to lung cancer via activating the pro-tumor macrophages T Chen, J Guo, L Ai, Y Wang, Y Wang, B Chen, M Liu, S Zhuang, K Liu, ... Computational and Structural Biotechnology Journal 21, 5751-5764, 2023 | 6 | 2023 |
| Revealing biomarkers associated with PARP inhibitors based on genetic interactions in cancer genome Q Dong, M Liu, B Chen, Z Zhao, T Chen, C Wang, S Zhuang, Y Li, Y Wang, ... Computational and structural biotechnology journal 19, 4435-4446, 2021 | 6 | 2021 |
| Synthetic viability induces resistance to immune checkpoint inhibitors in cancer cells M Liu, Q Dong, B Chen, K Liu, Z Zhao, Y Wang, S Zhuang, H Han, X Shi, ... British Journal of Cancer 129 (8), 1339-1349, 2023 | 5 | 2023 |
| An individualized transcriptional signature to predict the epithelial-mesenchymal transition based on relative expression ordering T Chen, Z Zhao, B Chen, Y Wang, F Yang, C Wang, Q Dong, Y Liu, ... Aging (Albany NY) 12 (13), 13172, 2020 | 5 | 2020 |
